Avid Bioservices Inc (CDMO)

[jazzbeerman]

jake,


PPHM has exclusive license to Thorpe's work for as long as PPHM makes the monthly sponsored research payments.

For UTSW to take the tech back, they would have to prove that PPHM has not tried to advance the tech, that PPHM had shelved or abandoned the tech, (and obviously they are advancing the tech). There are no deadlines. There are no grey area 'speed of advancing the tech' issues, nothing. PPHM is spending money researching and advancing bavi, which means that the tech is exclusively Peregrine's for as long as they want it, period.


BTW - UTSW, just a couple months ago, outlicensed a "next gen." anti-PS to guess who... - Peregrine.

(Schroit's "double" Beta-2-glycoprotein-I )



If you are disappointed in the rate of Bavi advance, (I'm not), you should look into the FDA's original inclusion/exclusion criteria for the first (1A) cancer trial, even after Peregrine's abundance of safety/tox data provided... Realize that targeting PS was seriously thought to be taboo, (and still is seen that way by many in the immunological science community who aren't up on the recent discoveries that have differentiated pathogenic from non-pathogenic autoantibodies, - especially those with plasma protein cofactors like bavi...)




j